Liru He

Overexpression of eIF5A‐2 is an adverse prognostic marker of survival in stage I non–small cell lung cancer patients

Liru He, Hongyun Zhao, Binkui Li et al. · International Journal of Cancer · 2010 · 95 citations · Full text

Medicine, Molecular Biology, Oncology +17

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

Liru He, Meng‐Zhong Liu, Binkui Li et al. · International Journal of Cancer · 2009 · 89 citations · Full text

Medicine, Cancer Biology, Oncology +17

Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

Liru He, Pamela K. Allen, Adam S. Potter et al. · Journal of Thoracic Oncology · 2014 · 65 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Nuclear targeting determinants of the far upstream element binding protein, a c-myc transcription factor

Liru He · Nucleic Acids Research · 2000 · 57 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

The telomere/telomerase binding factor <scp>PinX1</scp> is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas

Dong Qian, Bin Zhang, Liru He et al. · The Journal of Pathology · 2013 · 57 citations

Medicine, Cancer Biology, Oncology +17